Literature DB >> 12044340

Eclampsia in Sweden.

Gill Kullberg1, Solveig Lindeberg, Ulf Hanson.   

Abstract

OBJECTIVE: Assess the actual rate of eclampsia in Sweden, describe the clinical picture of the disease and the maternal and perinatal outcomes.
METHODS: Analysis of data regarding incidence of eclampsia registered in the Swedish Medical Birth Register 1991-1992. The records of all the cases with the diagnosis of eclampsia in Sweden during 1991-1992 were retrospectively evaluated regarding maternal and fetal outcomes.
RESULTS: The incidence of eclampsia after case review was 3.3/10,000 births. There was no maternal mortality. Severe maternal complications occurred in 30%. Recurrent fits were reported in 41%. Antenatal eclampsia was usually either not preceded by symptoms or signs of preeclampsia or by just a very short period of prodromal symptoms. Among intrapartum and postnatal cases of eclampsia, preeclampsia or high blood pressure was more frequently noted when convulsions occurred. Perinatal mortality rate was 4/80 (4.7%). Of the infants, 13% were small for gestational age.
CONCLUSION: Compared with earlier studies, the incidence of eclampsia has increased significantly. It is questionable whether the incidence of eclampsia could be reduced by earlier diagnosis and treatment of preeclampsia. The risk of severe complications and recurrent fits was substantial, which underlines the importance of adequate treatment of eclampsia.

Entities:  

Mesh:

Year:  2002        PMID: 12044340     DOI: 10.1081/PRG-120002906

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  8 in total

Review 1.  Magnesium sulphate versus diazepam for eclampsia.

Authors:  Lelia Duley; David J Henderson-Smart; Godfrey Ja Walker; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

Review 2.  Magnesium sulphate versus lytic cocktail for eclampsia.

Authors:  Lelia Duley; A Metin Gülmezoglu; Doris Chou
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

3.  The risk factors for labor onset hypertension.

Authors:  Yasumasa Ohno; Mikio Terauchi; Koji Tamakoshi; Arihiro Shiozaki; Shigeru Saito
Journal:  Hypertens Res       Date:  2015-10-22       Impact factor: 3.872

4.  Plasma levels of S100B in preeclampsia and association with possible central nervous system effects.

Authors:  Lina Bergman; Tansim Akhter; Anna-Karin Wikström; Johan Wikström; Tord Naessen; Helena Åkerud
Journal:  Am J Hypertens       Date:  2014-03-07       Impact factor: 2.689

5.  The burden of maternal morbidity and mortality attributable to hypertensive disorders in pregnancy: a prospective cohort study from Uganda.

Authors:  Annettee Nakimuli; Sarah Nakubulwa; Othman Kakaire; Michael Odongo Osinde; Scovia Nalugo Mbalinda; Nelson Kakande; Rose Chalo Nabirye; Dan Kabonge Kaye
Journal:  BMC Pregnancy Childbirth       Date:  2016-08-04       Impact factor: 3.007

6.  Risk factors and outcome of patients with eclampsia at a tertiary hospital in Egypt.

Authors:  Ahmad Mahran; Hashem Fares; Reham Elkhateeb; Mahmoud Ibrahim; Haitham Bahaa; Ahmad Sanad; Alaa Gamal; Mohamed Zeeneldin; Eissa Khalifa; Ahmed Abdelghany
Journal:  BMC Pregnancy Childbirth       Date:  2017-12-22       Impact factor: 3.007

7.  A five-year trend in pre-eclampsia admission and factors associated with inpatient eclampsia: a retrospective study from a resource-limited hospital in northeast Ethiopia.

Authors:  Kenean Getaneh Tlaye; Melese Linger Endalifer; Mikiyas Amare Getu; Addisu Getie Nigatu; Eleni Tesfaye Kebede
Journal:  BMJ Open       Date:  2021-02-05       Impact factor: 2.692

8.  The burden of eclampsia: results from a multicenter study on surveillance of severe maternal morbidity in Brazil.

Authors:  Juliana C Giordano; Mary A Parpinelli; Jose G Cecatti; Samira M Haddad; Maria L Costa; Fernanda G Surita; Joao L Pinto E Silva; Maria H Sousa
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.